                         SEQUENCE LISTING

<110>  Forschungszentrum Jlich
 
<120>  Verfahren zur selektiven Quantifizierung von A-Beta-Aggregaten

<130>  FZJ 1101 PCT

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  43
<212>  PRT
<213>  human

<400>  1

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys 
1               5                   10                  15      


Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile 
            20                  25                  30          


Gly Leu Met Val Gly Gly Val Val Ile Ala Thr 
        35                  40              


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid

<400>  2

Asp Ala Glu Phe Arg His Asp Ser 
1               5               


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid

<400>  3

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu 
1               5                   10      


<210>  4
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid

<400>  4

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys 
1               5                   10                  15      


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid

<400>  5

Glu Phe Arg His Asp Ser Gly Tyr Glu 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamate

<400>  6

Glu Phe Arg His Asp Ser Gly Tyr Glu 
1               5                   


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid

<400>  7

Glu Val His His Gln Lys 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptid


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  pyroglutamat

<400>  8

Glu Val His His Gln Lys 
1               5       


